Sign in Get started

Infectious Diseases

Filters2 filters applied

Status

Expression of concern
Corrected
No notice
From publisher notices and Retraction Watch. Not checked means nobody has looked yet.

Year

Readable here

Study type

Licence

516 papers1 Expression of concern 20 Corrected Questions on this topic

1 filter appliedReadable here: Full text Clear all

Hospitalizations Associated with COVID-19 Among Children and Adolescents — COVID-NET, 14 States, March 1, 2020–August 14, 2021
Miranda J. Delahoy, Dawud Ujamaa, Michael Whitaker et al. · MMWR. Morbidity and Mortality Weekly Report · 2021
Full textCC BY
Fifth-week immunogenicity and safety of anti-SARS-CoV-2 BNT162b2 vaccine in patients with multiple myeloma and myeloproliferative malignancies on active treatment: preliminary data from a single institution
Fulvia Pimpinelli, Francesco Marchesi, Giulia Piaggio et al. · Journal of Hematology & Oncology · 2021
Full textCC BY
Global seroprevalence of SARS-CoV-2 antibodies: A systematic review and meta-analysis
Niklas Bobrovitz, Rahul Krishan Arora, Christian Cao et al. · PLOS ONE · 2021 · Meta-analysis
Full textCC BY
Human IgG and IgA responses to COVID-19 mRNA vaccines
Adam V. Wisnewski, Julian Campillo Luna, Carrie A. Redlich · PLOS ONE · 2021
Full textCC BY
Prolonged evolution of the human B cell response to SARS-CoV-2 infection
Mrunal Sakharkar, C. Garrett Rappazzo, Wendy F. Wieland-Alter et al. · Science Immunology · 2021
Full textCC BY
Structure of papain-like protease from SARS-CoV-2 and its complexes with non-covalent inhibitors
Jerzy Osipiuk, Saara-Anne Azizi, Steve Dvorkin et al. · Nature Communications · 2021
Full textCC BY
Azole-resistant Aspergillus fumigatus in the environment: Identifying key reservoirs and hotspots of antifungal resistance
Caroline Burks, Alexandria Darby, Luisa Gómez Londoño et al. · PLOS Pathogens · 2021 · Review
Full textCC BY
Convergence of infectious and non-communicable disease epidemics in rural South Africa: a cross-sectional, population-based multimorbidity study
Emily B Wong, Stephen Olivier, Resign Gunda et al. · The Lancet Global Health · 2021
Full textCC BY
Trends in knowledge of HIV status and efficiency of HIV testing services in sub-Saharan Africa, 2000–20: a modelling study using survey and HIV testing programme data
Katia Giguère, Jeffrey W Eaton, Kimberly Marsh et al. · The Lancet HIV · 2021
Full textCC BY
Molecular mechanism of interaction between SARS-CoV-2 and host cells and interventional therapy
Qianqian Zhang, Rong Xiang, Shanshan Huo et al. · Signal Transduction and Targeted Therapy · 2021 · Review
Full textCC BY
A cohort autopsy study defines COVID-19 systemic pathogenesis
Xiao-Hong Yao, Tao Luo, Yu Shi et al. · Cell Research · 2021
Full textCC BY
Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine — United States, December 14–23, 2020
CDC COVID-19 Response Team, Food and Drug Administration · MMWR. Morbidity and Mortality Weekly Report · 2021
Full textCC BY
Nosocomial transmission and outbreaks of coronavirus disease 2019: the need to protect both patients and healthcare workers
Mohamed Abbas, Tomás Robalo Nunes, Romain Martischang et al. · Antimicrobial Resistance & Infection Control · 2021 · Review
Full textCC BY
Exponential growth, high prevalence of SARS-CoV-2, and vaccine effectiveness associated with the Delta variant
Paul Elliott, David Haw, Haowei Wang et al. · Science · 2021
Full textCC BY
COVID-19: Characteristics and Therapeutics
Rameswari Chilamakuri, Saurabh Agarwal · Cells · 2021 · Review
Full textCC BY
Orally delivered MK-4482 inhibits SARS-CoV-2 replication in the Syrian hamster model
Kyle Rosenke, Frederick Hansen, Benjamin Schwarz et al. · Nature Communications · 2021
Full textCC BY
Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms
Michael J. Peluso, Amelia N. Deitchman, Leonel Torres et al. · Cell Reports · 2021
Full textCC BY
Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19
Britton Boras, Rhys M. Jones, Brandon J. Anson et al. · Nature Communications · 2021
Full textCC BY
Effects of potent neutralizing antibodies from convalescent plasma in patients hospitalized for severe SARS-CoV-2 infection
Arvind Gharbharan, Carlijn C. E. Jordans, Corine GeurtsvanKessel et al. · Nature Communications · 2021 · Randomised trial
Full textCC BY
Weak immunogenicity of SARS-CoV-2 vaccine in patients with hematologic malignancies
Florent Malard, Béatrice Gaugler, Joel Gozlan et al. · Blood Cancer Journal · 2021
Full textCC BY